(Q37968318)

26 August 2017

title

Peak serum: implications of serum supply for cell therapy manufacturing (English)

1 reference

26 August 2017

David A Brindley

1

1 reference

26 August 2017

Natasha L Davie

2

1 reference

26 August 2017

Emily J Culme-Seymour

3

1 reference

26 August 2017

Chris Mason

4

1 reference

26 August 2017

David W Smith

5

1 reference

26 August 2017

Jon A Rowley

6

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

published in

Regenerative Medicine

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

7-13

1 reference

Cell therapy industry: billion dollar global business with unlimited potential.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

The impact of market volatility on the cell therapy industry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

Regenerative medicine bioprocessing: building a conceptual framework based on early studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

Alexis Carrel and the mysticism of tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

Peak water limits to freshwater withdrawal and use

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FRME.11.112

21 January 2018

Identifiers

DOI

10.2217/RME.11.112

1 reference

26 August 2017

1 reference